A Randomized Trial of Vaccine Adherence in Young Injection Drug Users (UFO VAX)
Medication Adherence, Substance Abuse, Intravenous, Risk Behavior
About this trial
This is an interventional prevention trial for Medication Adherence
Eligibility Criteria
Inclusion Criteria (screening study): age 14-29 at screening injected drugs in the prior 30 days Exclusion Criteria (screening study): Prior positive HIV antibody test Prior HBV immunization Inclusion Criteria (vaccine cohort): participated in the screening study tested negative for HIV-1 antibody and HBV markers in the screening study returned for screening test results within 30 days of testing
Sites / Locations
- University of California San Francisco Medical Cen
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
AIC, Hepatitis A & B vaccine
AIC, Outreach, Hepatitis A & B vaccine
SEP, Hepatitis A & B vaccine
SEP, Outreach, Hepatitis A & B vaccine
Subjects randomized to a public health department clinic, the Adult Immunization Clinic (AIC), for administration of viral hepatitis immunizations at Month 1, 2, 6.
AIC + outreach: Subjects randomized to a public health department clinic, the Adult Immunization Clinic (AIC)) for administration of viral hepatitis immunizations at Month 1, 2, 6, plus outreach worker adherence support to receive all immunizations
SEP only: Subjects randomized to a set of syringe exchange programs for administration of viral hepatitis immunizations at Month 1, 2, 6.
Subjects randomized to a set of syringe exchange programs for administration of viral hepatitis immunizations at Month 1, 2, 6, plus outreach worker adherence support to receive all immunizations